All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Compounded Semaglutide and Fertility

Compounded semaglutide should be stopped at least two months before trying to conceive. Learn about fertility effects, washout timing, PCOS...

By FormBlends Editorial Research|Source reviewed by FormBlends Medical Team||

Source Reviewed

Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team

Compounded Semaglutide and Fertility custom 2026 header image for GLP-1 Weight Loss
Custom header image for Compounded Semaglutide and Fertility, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Compounded Semaglutide and Fertility

Compounded semaglutide should be stopped at least two months before trying to conceive. Learn about fertility effects, washout timing, PCOS...

Short answer

Compounded semaglutide should be stopped at least two months before trying to conceive. Learn about fertility effects, washout timing, PCOS...

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Compounded semaglutide should be stopped at least two months before trying to conceive. Learn about fertility effects, washout timing, PCOS considerations, and contraception while on treatment.

Compounded semaglutide should be stopped at least two months before trying to conceive, following the same guidance that applies to brand-name semaglutide products. The active active ingredient is in the same class, meaning the same fertility precautions and washout timeline apply. At the same time, the weight loss compounded semaglutide provides may improve fertility for patients dealing with obesity-related reproductive challenges.

Compounded semaglutide has become a popular option for weight management, particularly for patients seeking more affordable access to GLP-1 therapy. Many of these patients are women of childbearing age who need clear guidance about how this medication relates to their reproductive plans.

Washout Period and Pregnancy Planning

Semaglutide, whether compounded or brand-name, has a half-life of approximately seven days. The two-month washout recommendation allows the drug to go through roughly eight half-lives, reducing circulating levels to negligible amounts.

This recommendation comes from animal reproductive studies that showed adverse fetal outcomes at doses higher than those used in humans. Because controlled human pregnancy data doesn't exist, the conservative approach is to ensure the drug is fully cleared before conception. Your prescriber can help you plan the transition from treatment to trying to conceive.

Weight Loss Benefits for Reproductive Health

Excess body weight interferes with fertility through several mechanisms: hormonal imbalances driven by adipose tissue, insulin resistance that disrupts ovulation, chronic low-grade inflammation, and increased pregnancy complication risks. For a complete cost breakdown, see our semaglutide pricing comparison.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Compounded Semaglutide and Fertility

Compounded semaglutide addresses these issues by promoting meaningful weight loss. Patients often lose 10% to 15% of their body weight, which can:

  • Restart regular ovulatory cycles in women who had stopped ovulating
  • Improve IVF and IUI success rates
  • Normalize reproductive hormone levels in both men and women
  • Lower the risk of miscarriage associated with obesity
  • Create a healthier metabolic environment for pregnancy

Compounding and Fertility: A Special Note

One question unique to compounded semaglutide is whether the compounding process affects safety differently than brand-name products. The active molecule in compounded semaglutide is the same as in Ozempic and Wegovy. But compounded medications are prepared by specialty pharmacies rather than the original manufacturer, and the inactive ingredients (excipients) may vary. compounded semaglutide

Get compounded semaglutide from $99/mo

Free provider review, personalized dosing, and ongoing support included.

Start Free Assessment →

From a fertility standpoint, the key safety considerations remain the same: stop at least two months before conception, use reliable contraception during treatment, and communicate with your provider about your family planning timeline. The washout period and precautions apply equally regardless of whether your semaglutide is compounded or brand-name.

Contraception During Treatment

Because semaglutide slows gastric emptying, there's a theoretical concern about reduced absorption of oral contraceptive pills. While this hasn't been definitively proven to cause contraceptive failure with semaglutide specifically, many providers recommend using a non-oral backup method or switching to a non-oral contraceptive altogether during treatment. IUDs, implants, and injectable contraceptives aren't affected.

Frequently Asked Questions

Is the fertility guidance for compounded semaglutide the same as for Ozempic?

Yes. The active ingredient is the same molecule, so the same precautions apply. Stop compounded semaglutide at least two months before planned pregnancy, use contraception during treatment, and discuss timing with your healthcare provider.

The weight loss and improved insulin sensitivity from compounded semaglutide can help restore ovulation in women with PCOS, just as brand-name semaglutide does. Some fertility specialists recommend a period of GLP-1 assisted weight loss before fertility treatment, followed by a washout before conception. semaglutide and PCOS

What if I get pregnant while on compounded semaglutide?

Stop the medication immediately and contact your healthcare provider. Brief early-pregnancy exposure hasn't been studied thoroughly in humans. Your provider will guide appropriate monitoring and follow-up care.

Does compounded semaglutide cause permanent infertility?

No evidence suggests that compounded semaglutide causes permanent infertility in humans. The recommendation to discontinue before pregnancy is precautionary. Many patients find that their fertility actually improves as a result of the weight loss achieved during treatment.

Should I use backup contraception while taking compounded semaglutide?

If you use oral birth control pills, adding a backup method is a reasonable precaution since semaglutide slows gastric emptying and could theoretically reduce pill absorption. Non-oral contraceptive methods like IUDs and implants aren't affected and may be a better fit during treatment.

This content is for informational purposes only and doesn't constitute medical advice. Always consult a qualified healthcare provider regarding fertility and medication decisions.

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Compounded Semaglutide and Fertility, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2019

GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis

Used for PCOS pages comparing metabolic and weight-management approaches.

PubMed

Systematic reviewPCOS and GLP-1 evidence2024

The efficacy and safety of GLP-1 agonists in PCOS women living with obesity

Supports PCOS, obesity, and hormonal-regulation context.

PubMed

Systematic reviewPCOS and GLP-1 evidence2026

GLP-1 receptor agonist treatment in women with polycystic ovary syndrome

Current review source for pages discussing GLP-1 treatment in PCOS.

PubMed

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Direct answer

Compounded Semaglutide and Fertility research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Compounded semaglutide should be stopped at least two months before trying to conceive. Learn about fertility effects, washout timing, PCOS considerations, and contraception while on treatment. Use "Compounded Semaglutide and Fertility" to make the conversation more specific before you choose a provider, product, or next step. The page leans into patient education and clinical context and the details behind semaglutide, safety and pharmacy quality. Because this article has 5 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. The safest takeaway is a better checklist for clinician review, not a do-it-yourself medical decision.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Verify the pharmacy pathway, certificate of analysis, sterility testing, and clinician oversight before trusting a source.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Compounded Semaglutide and Fertility

For this glp-1 weight loss page, the 2026 refresh focuses on semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, compounded so the article stays close to the question behind "Compounded Semaglutide and Fertility".

The useful details are the practical ones: what to verify, what changes risk or cost, and which details separate Compounded Semaglutide and Fertility from nearby GLP-1, peptide, hormone, or provider-comparison searches.

Readers can use the added context to bring sharper questions to a licensed provider before making a treatment, cost, or care decision.

Compounded Semaglutide and Fertility custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Compounded Semaglutide and Fertility, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Compounded Semaglutide and Fertility, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.